Your browser doesn't support javascript.
loading
Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.
Eggermont, Alexander M M; Blank, Christian U; Mandala, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus Jm; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C; Lupinacci, Robert; Krepler, Clemens; Ibrahim, Nageatte; Kicinski, Michal; Marreaud, Sandrine; van Akkooi, Alexander C; Suciu, Stefan; Robert, Caroline.
Afiliação
  • Eggermont AMM; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: alexander.eggermont@gustaveroussy.fr.
  • Blank CU; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Mandala M; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Long GV; Melanoma Institute Australia, The University of Sydney, and Mater and Royal North Shore Hospitals, Sydney, NSW, Australia.
  • Atkinson VG; Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Dalle S; Hospices Civils de Lyon Cancer Institute, Lyon, France.
  • Haydon A; Alfred Hospital, Melbourne, VIC, Australia.
  • Lichinitser M; Russian Oncology Scientific Centre, Moscow, Russia.
  • Khattak A; Fiona Stanley Hospital/University of Western Australia, Perth, WA, Australia.
  • Carlino MS; Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia.
  • Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Larkin J; Royal Marsden Hospital, London, United Kingdom.
  • Puig S; Hospital Clinic Universitari de Barcelona, Barcelona, Spain.
  • Ascierto PA; Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Rutkowski P; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Schadendorf D; Universitaetsklinikum - University Essen, Essen, Germany.
  • Koornstra R; Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
  • Hernandez-Aya L; Washington University School of Medicine, St. Louis, MO, USA.
  • Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
  • van den Eertwegh AJ; Amsterdam University Medical Center, Location VUMC, Amsterdam, the Netherlands.
  • Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France.
  • Gutzmer R; Skin Cancer Center, Hannover Medical School, Hannover, Germany.
  • Jamal R; Centre Hospitalier de l'Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, QC, Canada.
  • Lorigan PC; Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Lupinacci R; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Krepler C; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Ibrahim N; Merck & Co., Inc., Kenilworth, NJ, United States.
  • Kicinski M; EORTC Headquarters, Brussels, Belgium.
  • Marreaud S; EORTC Headquarters, Brussels, Belgium.
  • van Akkooi AC; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Suciu S; EORTC Headquarters, Brussels, Belgium.
  • Robert C; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.
Eur J Cancer ; 116: 148-157, 2019 07.
Article em En | MEDLINE | ID: mdl-31200321
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Melanoma / Estadiamento de Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Melanoma / Estadiamento de Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article